checkAd

     143  0 Kommentare Monopar and NorthStar Partner with Aragen for Testing of Novel Potential Therapeutic for Severe COVID-19 - Seite 3

    CONTACTS:

    For Monopar Therapeutics Inc.:
    Investor Relations:
    Kim R. Tsuchimoto
    Chief Financial Officer
    kimtsu@monopartx.com

    For NorthStar Medical Radioisotopes, LLC.:
    Investor Relations:
    Paul Estrem
    Senior Vice President and Chief Financial Officer
    pestrem@northstarnm.com

    Lesen Sie auch

    For Aragen Bioscience, Inc.:
    David Lustig
    dlustig@aragenbio.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Monopar and NorthStar Partner with Aragen for Testing of Novel Potential Therapeutic for Severe COVID-19 - Seite 3 WILMETTE, Ill. and BELOIT, Wis. and MORGAN HILL, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) - Monopar Therapeutics Inc. (Nasdaq: MNPR) (Wilmette, IL) and NorthStar Medical Radioisotopes, LLC (Beloit, WI), who are collaborating on the development of …